Opzioni
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience
2024
Periodico
HEMASPHERE
Abstract
N/A
DOI
Diritti
open access
license:creative commons
license:digital rights management non definito
license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/
license uri:iris.pri00
Soggetti
-
antigen expression
-
cancer prognosi
-
chronic lymphatic leu...
-
gene deletion
-
gene disruption
-
gene mutation
-
globulin blood level
-
high risk patient
-
high throughput seque...
-
human
-
intermediate risk pat...
-
lactate dehydrogenase...
-
Letter
-
low risk patient
-
overall survival
-
progression free surv...
-
scoring system
-
survival prediction
-
treatment failure
-
treatment outcome